Ajmalicine

• Catalog No.: Bio-0252
• CAS Number: 483-04-5
• M. F.: C21H24N2O3
• M. W.: 352.42686

SYNONYMS

• IUPAC name: methyl (1S,15R,16S,20S)-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0^2,^1^0.0^4,^9.0^1^5,^2^0]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate
• IUPAC Traditional name: methyl (1S,15R,16S,20S)-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0^2,^1^0.0^4,^9.0^1^5,^2^0]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate
• Synonyms: Lamuran; Py-tetrahydroserpentine; Raubasine; Tetrahydroserpentine; Vinceine; Delta-Yohimbine

DATABASE IDS

• CAS Number: 483-04-5

PROPERTIES

• Application(s): Antidiuretic agent
• Application(s): Vasodilator
• Application(s): CNS depressant
• Application(s): Has been used to treat peripheral and cerebral vascular disorders
• Biological Source: Alkaloid from Alstonia, Amsonia, Cabucala, Catharanthus, Mitragyna, Rauwolfia, Uncaria and Voacanga spp. (Apocynaceae, Naucleaceae)
• Mechanism of Action: Vasodilator
• Mechanism of Action: CYP2D6 inhibitor

REFERENCES

• Klohs, M.W. et al., J.A.C.S., 1954, 76, 1332, (isol, uv, ir)
• Antonaccio, L.D. et al., J.A.C.S., 1962, 84, 2161, (ms)
• Shamma, M. et al., J.A.C.S., 1963, 85, 2507, (ir, pmr, config)
• Laubie, M. et al., Arzneim.-Forsch., 1969, 19, 1820, (pharmacol)
• van Tamelen, E.E. et al., J.A.C.S., 1969, 91, 7359, (synth)
• Gutzwiller, J. et al., J.A.C.S., 1971, 93, 5907, (synth, ir, ms, pmr)
• Levin, R.H. et al., J.O.C., 1973, 38, 1983, (cmr)
• Lohr, J.P. et al., Arzneim.-Forsch., 1975, 25, 870, (metab)
• Brown, R.T. et al., Chem. Comm., 1977, 636, (synth)
• Hernandez, N.M.R. et al., Rev. Cubana Farm., 1977, 11, 249-255, (activity)
• Stckigt, J., Phytochemistry, 1979, 18, 965, (biosynth)
• Gutzwiller, J. et al., Helv. Chim. Acta, 1981, 64, 1663, (synth)
• Wenkert, E. et al., Acta Chem. Scand., Ser. B, 1982, 36, 607, (stereochem, configuration)
• Seguin, E. et al., Helv. Chim. Acta, 1983, 66, 2059, (cd)
• Massiot, G. et al., Chem. Comm., 1984, 715, (synth)
• Lala, P.K., J. Inst. Chem. (India), 1984, 56, 42, (ms)
• Hatakeyama, S. et al., Tet. Lett., 1985, 26, 865, (synth)
• Naito, T. et al., Heterocycles, 1986, 24, 2117, (synth)
• Mekkawi, A.G. et al., Anal. Profiles Drug Subst., 1987, 16, 731, (rev)
• Morales-Rios, M.S. et al., Magn. Reson. Chem., 1987, 25, 377, (cmr)
• Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th edn., Akademie-Verlag, 1987, 6133
• Takano, S. et al., Chem. Comm., 1988, 59, (synth)
• Hirai, Y. et al., J.A.C.S., 1988, 110, 958, (synth)
• Hanessian, S. et al., J.O.C., 1991, 56, 2947, (synth)
• Honda, T. et al., J.C.S. Perkin 1, 1993, 539
• Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 9277
• Lgers, M. et al., J.A.C.S., 1995, 117, 9139, (synth)
• Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, AFG750